Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients
Condition: Anemia in Incident Dialysis Patients Interventions: Drug: Roxadustat; Drug: Epoetin Alfa Sponsor: Second Xiangya Hospital of Central South University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials